Chromogranin a: Its known and possible roles in obstetrics and gynecology

1Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967;215:58-59.Blaschko H Comline RS Schneider FH Silver M Smith AD Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation Nature 196721558 5910.1038/215058a0Search in Google Scholar

2Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 1992;49:497-528.Winkler H Fischer-Colbrie R The chromogranins A and B: the first 25 years and future perspectives Neuroscience 199249497 52810.1016/0306-4522(92)90222-NSearch in Google Scholar

3Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR. The extended granin family: structure, function, and biomedical implications. Endocr Rev. 2011;32:755-797.Bartolomucci A Possenti R Mahata SK Fischer-Colbrie R Loh YP Salton SR The extended granin family: structure, function, and biomedical implications Endocr Rev 201132755 79710.1210/er.2010-0027359167521862681Search in Google Scholar

4O’Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab. 1983;57:1084-1086.O’Connor DT Burton D Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues J Clin Endocrinol Metab 1983571084 108610.1210/jcem-57-5-10846352725Search in Google Scholar

5Lloyd RV, Hawkins K, Jin L, Kulig E, Fields K. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen. Lab Invest. 1992;67:394-404.Lloyd RV Hawkins K Jin L Kulig E Fields K Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen. Lab Invest 199267394 404Search in Google Scholar

6Piotrowska Ż, Janiuk I, Lewandowska A, Kasacka I. Renovascular hypertensive decrease immunoreactivity of cells containing chromogranin A and pancreastatin in the pancreas of rats. Histol Histopathol. 2017;32:69-75.Piotrowska Ż Janiuk I Lewandowska A Kasacka I. Renovascular hypertensive decrease immunoreactivity of cells containing chromogranin A and pancreastatin in the pancreas of rats Histol Histopathol 20173269 75Search in Google Scholar

7Helman LJ, Gazdar AF, Park J-G, Cohen PS, Cotelingam JD, Israel MA. Chromogranin A expression in normal and malignant human tissues. J Clin Invest. 1988;82:686-690.Helman LJ Gazdar AF Park J-G Cohen PS Cotelingam JD Israel MA Chromogranin A expression in normal and malignant human tissues J Clin Invest 198882686 69010.1172/JCI1136483035643403722Search in Google Scholar

8Bandyopadhyay GK, Mahata SK. Chromogranin A regulation of obesity and peripheral insulin sensitivity. Front Endocrinol (Lausanne) 2017;8:20.Bandyopadhyay GK Mahata SK Chromogranin A regulation of obesity and peripheral insulin sensitivity Front Endocrinol (Lausanne) 201782010.3389/fendo.2017.00020529632028228748Search in Google Scholar

9Corti A, Marcucci F, Bachetti T. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. Pflugers Arch. 2018;470:199-210.Corti A Marcucci F Bachetti T Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers Pflugers Arch 2018470199 21010.1007/s00424-017-2030-y29018988Search in Google Scholar

10Sánchez-Margalet V, González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am J Physiol. 1998;275:E1055-E1060.Sánchez-Margalet V González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes Am J Physiol 1998275E1055 E106010.1152/ajpendo.1998.275.6.E10559843749Search in Google Scholar

11Wollam J, Mahata S, Riopel M, Hernandez-Carretero A, Biswas A, Bandyopadhyay GK, Chi NW, Eiden LE, Mahapatra NR, Corti A, Webster NJG, Mahata SK. Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion. Cell Tissue Res. 2017;368:487-501.Wollam J Mahata S Riopel M Hernandez-Carretero A Biswas A Bandyopadhyay GK Chi NW Eiden LE Mahapatra NR Corti A Webster NJG Mahata SK Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion Cell Tissue Res 2017368487 50110.1007/s00441-017-2580-528220294Search in Google Scholar

12Broedbaek K, Hilsted L. Chromogranin A as biomarker in diabetes. Biomark Med. 2016;10:1181-1189.Broedbaek K Hilsted L Chromogranin A as biomarker in diabetes Biomark Med 2016101181 118910.2217/bmm-2016-009127611656Search in Google Scholar

13Florio P, Mezzesimi A, Turchetti V, Severi FM, Ticconi C, Forconi S, Petraglia F. High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturition. J Soc Gynecol Investig. 2002;9:32-36.Florio P Mezzesimi A Turchetti V Severi FM Ticconi C Forconi S Petraglia F High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturition J Soc Gynecol Investig 2002932 3610.1177/107155760200900107Search in Google Scholar

14Syversen U, Opsjøn SL, Stridsberg M, Sandvik AK, Dimaline R, Tingulstad S, Arntzen KJ, Brenna E, Waldum HL. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies. J Clin Endocrinol Metab. 1996;81:4470-4475.Syversen U Opsjøn SL Stridsberg M Sandvik AK Dimaline R Tingulstad S Arntzen KJ Brenna E Waldum HL Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies J Clin Endocrinol Metab 1996814470 4475Search in Google Scholar

15Tsubouchi H, Nakai Y, Toda M, Morimoto K, Chang YS, Ushioda N, Kaku S, Nakamura T, Kimura T, Shimoya K. Change of salivary stress marker concentrations during pregnancy: maternal depressive status suppresses changes of those levels. J Obstet Gynaecol Res. 2011;37:1004-1009.Tsubouchi H Nakai Y Toda M Morimoto K Chang YS Ushioda N Kaku S Nakamura T Kimura T Shimoya K Change of salivary stress marker concentrations during pregnancy: maternal depressive status suppresses changes of those levels J Obstet Gynaecol Res 2011371004 100910.1111/j.1447-0756.2010.01473.x21463431Search in Google Scholar

16Moftaquir-Handaj A, Barbé F, Barbarino-Monnier P, Aunis D, Boutroy MJ. Circulating chromogranin A and catecholamines in human fetuses at uneventful birth. Pediatr Res. 1995;37:101-105.Moftaquir-Handaj A Barbé F Barbarino-Monnier P Aunis D Boutroy MJ. Circulating chromogranin A and catecholamines in human fetuses at uneventful birth Pediatr Res 199537101 10510.1203/00006450-199501000-000197700724Search in Google Scholar

17Van Reempts PJ, Wouters AN, Laroche S, Pinxteren J, De Potter W, Vanderauwera JC, Van Acker KJ. Umbilical cord dopamine beta-hydroxylase, chromogranin A and met-enkephalin after conditions associated with chronic intrauterine stress. Biol Neonate 1996;69:22-29.Van Reempts PJ Wouters AN Laroche S Pinxteren J De Potter W Vanderauwera JC Van Acker KJ Umbilical cord dopamine beta-hydroxylase, chromogranin A and met-enkephalin after conditions associated with chronic intrauterine stress Biol Neonate 19966922 2910.1159/0002442748777245Search in Google Scholar

18Schneider H. Placental dysfunction as a key element in the pathogenesis of preeclampsia. Dev Period Med. 2017;21:163-170.Schneider H Placental dysfunction as a key element in the pathogenesis of preeclampsia Dev Period Med 201721163 170Search in Google Scholar

19Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40-49.Ness RB Sibai BM Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia Am J Obstet Gynecol 200619540 4910.1016/j.ajog.2005.07.04916813742Search in Google Scholar

20Jauniaux E, Burton GJ. Pathophysiology of histological changes in early pregnancy loss. Placenta 2005;26:114-123.Jauniaux E Burton GJ Pathophysiology of histological changes in early pregnancy loss Placenta 200526114 12310.1016/j.placenta.2004.05.01115708112Search in Google Scholar

21Nicol L, McNeilly JR, Stridsberg M, Crawford JL, McNeilly AS. Influence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LβT2 gonadotroph cells. J Endocrinol. 2002;174:473-483.Nicol L McNeilly JR Stridsberg M Crawford JL McNeilly AS Influence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LβT2 gonadotroph cells J Endocrinol 2002174473 48310.1677/joe.0.174047312208668Search in Google Scholar

22Zhao E, McNeilly JR, McNeilly AS, Fischer-Colbrie R, Basak A, Seong JY, Trudeau VL. Secretoneurin stimulates the production and release of luteinizing hormone in mouse LβT2 gonadotropin cells. Am J Physiol Endocrinol Metab. 2011;301:E288-E297.Zhao E McNeilly JR McNeilly AS Fischer-Colbrie R Basak A Seong JY Trudeau VL Secretoneurin stimulates the production and release of luteinizing hormone in mouse LβT2 gonadotropin cells Am J Physiol Endocrinol Metab 2011301E288 E29710.1152/ajpendo.00070.2011315453221521715Search in Google Scholar

23Matsumoto T, Asakura H, Hayashi T. Increased salivary chromogranin A in women with severe negative mood states in the premenstrual phase. J Psychosom Obstet Gynaecol. 2012;33:120-128.Matsumoto T Asakura H Hayashi T Increased salivary chromogranin A in women with severe negative mood states in the premenstrual phase J Psychosom Obstet Gynaecol 201233120 12810.3109/0167482X.2012.69749822779913Search in Google Scholar

24Tamura T, Jobo T, Watanabe J, Kanai T, Kuramoto H. Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium. Int J Gynecol Cancer 2006;16:821-826.Tamura T Jobo T Watanabe J Kanai T Kuramoto H Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium Int J Gynecol Cancer 200616821 82610.1111/j.1525-1438.2006.00419.x16681768Search in Google Scholar